Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Dentsply Pharm Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for DENTSPLY PHARM, and what generic and branded alternatives to DENTSPLY PHARM drugs are available?

DENTSPLY PHARM has eight approved drugs.

Summary for Dentsply Pharm
US Patents:0

Drugs and US Patents for Dentsply Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dentsply Pharm DURANEST epinephrine bitartrate; etidocaine hydrochloride INJECTABLE;INJECTION 021384-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial
Dentsply Pharm CITANEST FORTE DENTAL epinephrine bitartrate; prilocaine hydrochloride INJECTABLE;INJECTION 021383-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes   Start Trial   Start Trial
Dentsply Pharm POLOCAINE W/ LEVONORDEFRIN levonordefrin; mepivacaine hydrochloride INJECTABLE;INJECTION 089517-001 Apr 14, 1988 DISCN No No   Start Trial   Start Trial
Dentsply Pharm XYLOCAINE DENTAL lidocaine hydrochloride INJECTABLE;INJECTION 021380-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Dentsply Pharm POLOCAINE mepivacaine hydrochloride INJECTABLE;INJECTION 088653-001 Aug 21, 1984 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.